Cutaneous angiosarcoma: update on biology and latest treatment.

about

Radiogenic angiosarcoma of the breast: case report and systematic review of the literature.

P2860

Q55401083-DE2BBD91-8033-4007-B356-38028C108946

P2860

Cutaneous angiosarcoma: update on biology and latest treatment.

Item

http://www.wikidata.org/entity/Q47807442

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Cutaneous angiosarcoma: update on biology and latest treatment.

@en

Cutaneous angiosarcoma: update on biology and latest treatment.

@nl

type

Item

label

Cutaneous angiosarcoma: update on biology and latest treatment.

@en

Cutaneous angiosarcoma: update on biology and latest treatment.

@nl

prefLabel

Cutaneous angiosarcoma: update on biology and latest treatment.

@en

Cutaneous angiosarcoma: update on biology and latest treatment.

@nl

P1476

Cutaneous angiosarcoma: update on biology and latest treatment.

@en

P2093

Kenji Kabashima

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International

P2860

Patient Management with Eribulin in Metastatic Breast Cancer: A Clinical Practice Guide

Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study.

Pazopanib does not bring remarkable improvement in patients with angiosarcoma.

Recurrent PTPRB and PLCG1 mutations in angiosarcoma.

Systemic Therapy for Soft Tissue Sarcoma: Proposals for the Optimal Use of Pazopanib, Trabectedin, and Eribulin

Initiation and use of propranolol for infantile hemangioma: report of a consensus conference.

Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial.

Targeted therapy with propranolol and metronomic chemotherapy combination: sustained complete response of a relapsing metastatic angiosarcoma.

Targeted massively parallel sequencing of angiosarcomas reveals frequent activation of the mitogen activated protein kinase pathway

Src activation by β-adrenoreceptors is a key switch for tumour metastasis.

P304

107-112

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1097/CCO.0000000000000427

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Yoshihiro Ishida

Atsushi Otsuka

P577

2018-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29194075

http://www.w3.org/2001/XMLSchema#string

P921

skin neoplasm

hemangiosarcoma

P932

5815647

http://www.w3.org/2001/XMLSchema#string

Cutaneous angiosarcoma: update on biology and latest treatment.

about

P2860

P2860

Cutaneous angiosarcoma: update on biology and latest treatment.

description

name

type

label

prefLabel

P1433

P1476

P2093

P275

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P275

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932